China Universal Asset Management Company’s NewAmsterdam Pharma NAMS Stock Holding History

China Universal Asset Management Company’s Portfolio NAMS Stock Details NAMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.65M	Buy	48,605 +4,902	+11%	+$162K	0.1%	150
2026 Q1	$1.4M	Buy	43,703 +17,226	+65%	+$561K	0.11%	153
2025 Q4	$929K	Buy	26,477 +6,735	+34%	+$245K	0.07%	196
2025 Q3	$561K	Sell	19,742 -2,807	-12%	-$67.3K	0.05%	234
2025 Q2	$408K	Buy	22,549 +521	+2%	+$9.5K	0.04%	254
2025 Q1	$451K	Buy	22,028 +2,439	+12%	+$54.2K	0.04%	252
2024 Q4	$503K	Buy	+19,589	New	+$416K	0.05%	250

Other funds holding NAMS

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

MVM

Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

China Universal Asset Management Company's NAMS Position: Q2 2026 in Review

China Universal Asset Management Company increased its NewAmsterdam Pharma (NAMS) stake by 11% in Q2 2026, buying an estimated $162K and bringing the position to 48,605 shares worth $1.65M. The position accounts for 0.1% of the portfolio, ranked #150.

China Universal Asset Management Company first reported a position in NAMS in Q4 2024 and has held it in 7 quarters since. 93 funds tracked by Wall St. Rank hold NAMS as of Q2 2026.

China Universal Asset Management Company held 48,605 shares of NewAmsterdam Pharma worth $1.65M as of Q2 2026.
China Universal Asset Management Company bought 4,902 NewAmsterdam Pharma shares in Q2 2026, an estimated $162K.
NewAmsterdam Pharma made up 0.1% of China Universal Asset Management Company's portfolio in Q2 2026, its #150 holding.
China Universal Asset Management Company first reported a position in NewAmsterdam Pharma in Q4 2024 and has held it in 7 quarters since.
93 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.